News

Shares of Carisma Therapeutics Inc. (CARM) have been struggling lately and have lost 12.1% over the past week. However, a hammer chart pattern was formed in its last trading session, which could ...
Carisma Therapeutics Inc. (CARM) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings ...
The current price CARISMA Therapeutics (CARM) is trading at is $0.20, which is out of the analyst’s predicted range. Browse analyst ratings and price targets on all stocks. People Also Watch ...